T. Rowe Price Associates’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-7,038
| Closed | -$98K | – | 3023 |
|
|
2021
Q3 | $98K | Hold |
7,038
| – | – | ﹤0.01% | 2845 |
|
|
2021
Q2 | $131K | Sell |
7,038
-338
| -5% | -$6.29K | ﹤0.01% | 2801 |
|
|
2021
Q1 | $172K | Buy |
+7,376
| New | +$172K | ﹤0.01% | 2717 |
|
|
2020
Q2 | – | Sell |
-120,076
| Closed | -$5.78M | – | 2524 |
|
|
2020
Q1 | $5.78M | Sell |
120,076
-34,523
| -22% | -$1.66M | ﹤0.01% | 1316 |
|
|
2019
Q4 | $8.79M | Sell |
154,599
-6,143
| -4% | -$349K | ﹤0.01% | 1332 |
|
|
2019
Q3 | $9.97M | Sell |
160,742
-24,483
| -13% | -$1.52M | ﹤0.01% | 1292 |
|
|
2019
Q2 | $8.34M | Sell |
185,225
-11,506
| -6% | -$518K | ﹤0.01% | 1342 |
|
|
2019
Q1 | $12.4M | Buy |
196,731
+9,650
| +5% | +$607K | ﹤0.01% | 1287 |
|
|
2018
Q4 | $10.1M | Sell |
187,081
-28
| -0% | -$1.51K | ﹤0.01% | 1302 |
|
|
2018
Q3 | $18.8M | Sell |
187,109
-4,015
| -2% | -$403K | ﹤0.01% | 1251 |
|
|
2018
Q2 | $12.6M | Sell |
191,124
-17,621
| -8% | -$1.16M | ﹤0.01% | 1303 |
|
|
2018
Q1 | $10.4M | Buy |
208,745
+231
| +0.1% | +$11.6K | ﹤0.01% | 1321 |
|
|
2017
Q4 | $10.1M | Buy |
208,514
+175
| +0.1% | +$8.47K | ﹤0.01% | 1329 |
|
|
2017
Q3 | $12.7M | Sell |
208,339
-29,918
| -13% | -$1.82M | ﹤0.01% | 1286 |
|
|
2017
Q2 | $16.9M | Buy |
238,257
+162,089
| +213% | +$11.5M | ﹤0.01% | 1224 |
|
|
2017
Q1 | $4.94M | Buy |
76,168
+1,049
| +1% | +$68K | ﹤0.01% | 1431 |
|
|
2016
Q4 | $7.06M | Sell |
75,119
-4,937
| -6% | -$464K | ﹤0.01% | 1376 |
|
|
2016
Q3 | $9.04M | Buy |
+80,056
| New | +$9.04M | ﹤0.01% | 1335 |
|